Orphan Therapeutics Accelerator Announces Foundational Partnerships
Founding Members Chiesi, BIAL Lead Initial Funding;
Landmark Bio, Uncommon Cures Join Clinical Development Network;
DVLP Medicines, Vibe Bio to Provide Integrated AI-based Solutions
